none

CSIRO IS ON A HEALTH KICK

05-09-2017
by 
in 
CSIRO M2 programme

Breakthroughs and remarkable discoveries are expected from the new "M2" programme between CSIRO and Monash University, as the two scientific behemoths collaborate to "bring the best minds and technology together to turn great ideas into a reality for Australia’s flourishing medtech industry". 

As innovation continues to be the watchword for Australian industry, efforts by the government to reinvest in science and technology are continuing apace. 

“From life-changing cochlear implants, to life-saving vaccines, world-first 3D printed bone and tissue replacements, Australia has an incredible track record when it comes to medical technologies and pharmaceuticals,” Senator Arthur Sinodinos said.

“M2 will help to accelerate development of technology like this, not only vital for the improvement of the lives of Australians facing medial challenges, but also leading to job and economic growth for Australia.”

Supported by the Science and Industry Endowment fund, M2 aims to bridge the gap between Australia's many small- and medium-sized medical technology enterprises, and the often-exorbitant cost of prototyping and developing new products. 

M2 will be providing a research ecosystem for these companies, helping to transition new discoveries from the bench to prototyping, pre-clinical testing, industry evaluation and commercialisation.

“M2 leverages some of Australia’s best medtech expertise, experience and equipment,” CSIRO Director of Manufacturing Dr Keith McLean said.

“When a company comes to us we can use CSIRO and MHTP facilities to develop and analyse production scale prototypes, whilst the Monash Biomedical Imaging facility can provide advanced pre-clinical and clinical testing and imaging.”

With global populations ageing and emerging markets seeking better health care, there’s huge growth underway in the MTP sector. It’s expected to be worth almost $3 trillion by 2025, while $18 billion and 28,000 new jobs could be added to the Australian economy over the next eight years.

“Monash is determined to help build a new, globally competitive biomedical industry with our partners,” Monash University Provost and Senior Vice-President Professor Marc Parlange said.

“This initiative will deliver real health benefits to all Australians. Our healthcare spending is expected to almost double to 16 per cent of GDP by 2040. Cheaper and more effective medical solutions are better for our health and Australia’s financial future.”

Related news & editorials

  1. 17.05.2019
    17.05.2019
    by      In
    A new energy management system developed by the University of South Australia will be road tested during the 2019 Bridgestone World Solar Challenge through central Australia in October.
    UniSA PhD student Erika Belchamber has developed a technique that maximises efficiency in balancing solar input,... Read More
  2. 16.05.2019
    16.05.2019
    by      In
    The last few years have been tough for the oil and gas industry, resulting in some hard decisions around cutting costs and postponing projects. Thankfully, sentiment in the industry has recently been turning into one of cautious optimism. The time is now right to look at new technological... Read More
  3. 16.05.2019
    16.05.2019
    by      In
    Operating in 27 countries, Netherlands-based Boon Edam supplies security doors, gates and turnstiles to some of the world’s biggest companies and public agencies. Since establishing a permanent Australian subsidiary, Boon Edam has steadily provided its Australian, New Zealand and Papua New Guinean... Read More
  4. 16.05.2019
    16.05.2019
    by      In
    The Australian Clean Energy Electric Vehicle Group (ACE-EV) has signed a deal to begin assembling carbon fibre composite and plastic electric vans at the Aldom manufacturing plant in Wingfield, in Adelaide’s northern suburbs, this year.
    ACE-EV managing director Greg McGarvie says he is determined... Read More